Skip to main content

Table 1 Survival rate after neoadjuvant radio-chemotherapy for locally advanced adenocarcinoma

From: The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract

Study Adeno-carcinoma n (%) Survival RTX Survival Surgery p-value
Walsh et al. 1996 [7] 113 (100%) 32% (3 y) 6% (3 y) 0.01
Urba et al. 2001 [43] 75 (75%) 30% (3 y) 16% (3 y) 0.15
Burmeister et al. 2005 [44] 158 (62%) 28% (3 y) 30% (3 y) 0.81
Tepper et al. 2008 [45] 42 (75%) 39% (5 y) 16% (5 y) 0.002
Stahl et al. 2009 [8] 119 (100%) 47.7% (3 y) 27.4% 0.07
    (CHX, 3 y)  
  1. RTX = radio-chemotherapy, CHX = chemotherapy, y = years